Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 943,700 | 894,800 | 888,500 | 821,500 | 841,800 |
| Cost of Goods | 246,200 | 233,600 | 235,300 | 213,300 | 211,100 |
| Gross Profit | 697,500 | 661,200 | 653,200 | 608,200 | 630,700 |
| Operating Expenses | 445,600 | 409,300 | 349,000 | 380,800 | 382,100 |
| Operating Income | 252,100 | 252,500 | 304,500 | 227,700 | 248,700 |
| Interest Expense | 0 | 0 | 19,300 | 100 | 1,400 |
| Other Income | -1,100 | 11,000 | 38,700 | -15,800 | -41,700 |
| Pre-tax Income | 251,000 | 263,500 | 323,900 | 211,800 | 205,600 |
| Income Tax | -31,700 | 56,900 | 326,700 | 41,700 | 19,500 |
| Net Income Continuous | 282,700 | 206,600 | -2,800 | 170,100 | 186,100 |
| Net Income | $282,700 | $206,600 | $-2,800 | $170,100 | $186,100 |
| EPS Basic Total Ops | 0.45 | 0.33 | 0.00 | 0.27 | 0.29 |
| EPS Basic Continuous Ops | 0.45 | 0.33 | 0.00 | 0.27 | 0.29 |
| EPS Diluted Total Ops | 0.44 | 0.32 | 0.00 | 0.26 | 0.29 |
| EPS Diluted Continuous Ops | 0.44 | 0.32 | 0.00 | 0.26 | 0.29 |
| EBITDA(a) | $271,300 | $271,600 | $325,700 | $248,400 | $267,600 |